The ternary complex factor net regulates cell migration through inhibition of PAI-1 expression

被引:46
作者
Buchwalter, G [1 ]
Gross, C [1 ]
Wasylyk, B [1 ]
机构
[1] ULP, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France
关键词
D O I
10.1128/MCB.25.24.10853-10862.2005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Net, Elk-1, and Sap-1 are members of the ternary complex factor (TCF) subfamily of Ets transcription factors. They form ternary complexes with serum response factor (SPF) on serum response elements of immediate early genes such as c-fos and egr-1 and mediate responses to growth factors and mitogen-activated protein kinase signaling. Although the TCFs have been extensively studied as intermediates in signaling cascades, surprisingly little is known about their different target genes and physiological functions. We report that Net homozygous mutant mouse embryonic fibroblasts have a defect in cell migration. This defect results at least in part from increased expression of plasminogen activator inhibitor type 1 (PAI-1), a serine protease inhibitor (serpin) that controls extracellular proteolysis and cell matrix adhesion. The defect in cell migration can be reverted by the addition of a PAI-1 blocking antibody. Net represses PAI-1 promoter activity and binds to a specific region of the promoter containing Ets binding sites in the absence of SRF. We conclude that Net is a negative regulator of PAI-1 expression and is thereby involved in cell migration.
引用
收藏
页码:10853 / 10862
页数:10
相关论文
共 69 条
[31]   Normal scarring:: importance of myofibroblasts [J].
Lorena, D ;
Uchio, K ;
Costa, AMA ;
Desmoulière, A .
WOUND REPAIR AND REGENERATION, 2002, 10 (02) :86-92
[32]   Expression of urokinase-type plasminogen activator, its receptor and type-1 plasminogen activator inhibitor is differently regulated by inhibitors of protein synthesis in human cancer cell lines [J].
Lund, LR .
FEBS LETTERS, 1996, 383 (03) :139-144
[33]   Inhibition of metastasis of intraocular melanomas by adenovirus-mediated gene transfer of plasminogen activator inhibitor type I (PAI-1) in an athymic mouse model [J].
Ma, D ;
Gerard, RD ;
Li, XY ;
Alizadeh, H ;
Niederkorn, JY .
BLOOD, 1997, 90 (07) :2738-2746
[34]   Net (ERP/SAP2), one of the Ras-inducible TCFs, has a novel inhibitory domain with resemblance to the helix-loop-helix motif [J].
Maira, SM ;
Wurtz, JM ;
Wasylyk, B .
EMBO JOURNAL, 1996, 15 (21) :5849-5865
[35]   Wound healing - Aiming for perfect skin regeneration [J].
Martin, P .
SCIENCE, 1997, 276 (5309) :75-81
[36]   Sp1-like activity mediates angiotensin-II-induced plasminogen-activator inhibitor type-1 (PAI-1) gene expression in mesangial cells [J].
Motojima, M ;
Ando, T ;
Yoshioka, T .
BIOCHEMICAL JOURNAL, 2000, 349 :435-441
[37]   Plasminogen activator inhibitor-1 and-3 increase cell adhesion and motility of MDA-MB-435 breast cancer cells [J].
Palmieri, D ;
Lee, JW ;
Juliano, RL ;
Church, FC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (43) :40950-40957
[38]   Reduction of tumor cell migration and metastasis by adenoviral gene transfer of plasminogen activator inhibitors [J].
Praus, M ;
Wauterickx, K ;
Collen, D ;
Gerard, RD .
GENE THERAPY, 1999, 6 (02) :227-236
[39]   Both u-Pa inhibition and vitronectin binding by plasminogen activator inhibitor 1 regulate HT1080 fibrosarcoma cell metastasis [J].
Praus, M ;
Collen, D ;
Gerard, RD .
INTERNATIONAL JOURNAL OF CANCER, 2002, 102 (06) :584-591
[40]   PAl-1 expression is required for epithelial cell migration in two distinct phases of in vitro wound repair [J].
Providence, KM ;
Higgins, PJ .
JOURNAL OF CELLULAR PHYSIOLOGY, 2004, 200 (02) :297-308